Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
43.83
-0.22 (-0.50%)
At close: Mar 6, 2026, 4:00 PM EST
43.65
-0.18 (-0.41%)
After-hours: Mar 6, 2026, 7:59 PM EST

Medline Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Revenue
28,43225,50723,23121,448
Revenue Growth (YoY)
11.47%9.80%8.31%-
Cost of Revenue
20,91418,53117,34616,231
Gross Profit
7,5186,9765,8855,217
Selling, General & Admin
4,5674,1083,8673,676
Amortization of Goodwill & Intangibles
704685662660
Other Operating Expenses
6835-5520
Operating Expenses
5,3394,8284,4744,356
Operating Income
2,1792,1481,411861
Interest Expense
-945-1,144-1,213-899
Interest & Investment Income
13328023727
Currency Exchange Gain (Loss)
-887-1111
Other Non Operating Income (Expenses)
-6-11110
EBT Excluding Unusual Items
1,2731,28042510
Legal Settlements
33-2-161-
Other Unusual Items
-58-32--
Pretax Income
1,2481,24626410
Income Tax Expense
91463035
Earnings From Continuing Operations
1,1571,200234-25
Minority Interest in Earnings
2---
Net Income
1,1591,200234-25
Net Income to Common
1,1591,200234-25
Net Income Growth
-3.42%412.82%--
Shares Outstanding (Basic)
81017,46717,500-
Shares Outstanding (Diluted)
81017,46717,500-
Shares Change (YoY)
-95.36%-0.19%--
EPS (Basic)
1.430.070.01-
EPS (Diluted)
1.430.070.01-
EPS Growth
1982.77%413.80%--
Free Cash Flow
1,2641,4051,400-67
Free Cash Flow Per Share
1.560.080.08-
Gross Margin
26.44%27.35%25.33%24.32%
Operating Margin
7.66%8.42%6.07%4.01%
Profit Margin
4.08%4.71%1.01%-0.12%
Free Cash Flow Margin
4.45%5.51%6.03%-0.31%
EBITDA
3,1903,1252,3621,794
EBITDA Margin
11.22%12.25%10.17%8.36%
D&A For EBITDA
1,011977951933
EBIT
2,1792,1481,411861
EBIT Margin
7.66%8.42%6.07%4.01%
Effective Tax Rate
7.29%3.69%11.36%350.00%
Source: S&P Capital IQ. Standard template. Financial Sources.